Achillion Pharmaceuticals, Inc logo
VerifiedPharmaceutical Manufacturing

Achillion Pharmaceuticals, Inc

On January 28, 2020, Achillion Pharmaceuticals was acquired by Alexion Pharmaceuticals, Inc. As part of Alexion, we are continuing to advance a clinical-stage portfolio of orally administered factor D inhibitors and working toward the mission of transforming the lives of people with rare diseases.”

7-day free trial · no credit card

HeadquartersBlue Bell, United StatesEmployees41(51 to 200)Annual revenue$1B+Websitealexion.comLinkedIn profileLinkedIn

Verified contacts

39

available on Kipplo

LinkedIn employees

41

51 to 200 range

Open roles

—

no listings

Distinct roles

35

indexed titles

Tech stack

0

tools in use

Monthly traffic

—

organic / mo

Sign up free to see all 39 verified contacts at Achillion Pharmaceuticals, Inc

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

39 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Achillion Pharmaceuticals, Inc

35 distinct titles indexed · top 10 shown.

  • 3principal scientist
  • 2administrative assistant
  • 2senior territory manager
  • 1abdelhadi
  • 1architect
  • 1assistant
  • 1associate director of antiviral drug discovery
  • 1bonjour
  • 1chief of facility operations
  • 1director of clinical development
  • +25more titles

Sign up to unlock all 39 contacts at Achillion Pharmaceuticals, Inc

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 39 verified contacts at Achillion Pharmaceuticals, Inc

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Achillion Pharmaceuticals, Inc | Kipplo Discover